ArticleFrontiers in immunology2026

Surgery vs. non-surgery for advanced cholangiocarcinoma post-conversion therapy with PD-1/PD-L1 inhibitors plus TKIs.

Zengpeng Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.